Prosecution Insights
Last updated: April 19, 2026

Surge Therapeutics Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18021634 IMMUNE MODULATION OF MYELOID DERIVED SUPPRESSIVE CELL FUNCTION FOR CANCER TREATMENT POPA, ILEANA 1633 Non-Final OA Feb 16, 2023
18016096 PREPARATIONS AND COMPOSITIONS COMPRISING POLYMER COMBINATION PREPARATIONS WERTZ, ASHLEE ELIZABETH 1612 Final Rejection Jan 13, 2023

Managing Surge Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month